These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34838653)

  • 1. Lasers, lights, and compounds for melasma in aesthetics.
    Kamal K; Heitmiller K; Christman M
    Clin Dermatol; 2022; 40(3):249-255. PubMed ID: 34838653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
    Geddes ER; Stout AB; Friedman PM
    Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laser-assisted delivery of tranexamic acid for melasma: Pilot study using a novel 1927 nm fractional thulium fiber laser.
    Wang JV; Christman MP; Feng H; Ferzli G; Jeon H; Geronemus RG
    J Cosmet Dermatol; 2021 Jan; 20(1):105-109. PubMed ID: 33174686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
    Rivas S; Pandya AG
    Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
    Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
    Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melasma: A critical analysis of clinical trials investigating treatment modalities published in the past 10 years.
    Spierings NMK
    J Cosmet Dermatol; 2020 Jun; 19(6):1284-1289. PubMed ID: 31603285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melasma Treatment: An Evidence-Based Review.
    McKesey J; Tovar-Garza A; Pandya AG
    Am J Clin Dermatol; 2020 Apr; 21(2):173-225. PubMed ID: 31802394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal azelaic acid 20% cream vs hydroquinone 4% cream as adjuvant to oral tranexamic acid in melasma: a comparative study.
    Akl EM
    J Dermatolog Treat; 2022 Jun; 33(4):2008-2013. PubMed ID: 33823725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-applied topical interventions for melasma: a systematic review and meta-analysis of data from randomized, investigator-blinded clinical trials.
    Pennitz A; Kinberger M; Avila Valle G; Passeron T; Nast A; Werner RN
    Br J Dermatol; 2022 Sep; 187(3):309-317. PubMed ID: 35290681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study.
    Wanitphakdeedecha R; Sy-Alvarado F; Patthamalai P; Techapichetvanich T; Eimpunth S; Manuskiatti W
    Lasers Med Sci; 2020 Dec; 35(9):2015-2021. PubMed ID: 32506227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melasma treatment: a systematic review.
    Neagu N; Conforti C; Agozzino M; Marangi GF; Morariu SH; Pellacani G; Persichetti P; Piccolo D; Segreto F; Zalaudek I; Dianzani C
    J Dermatolog Treat; 2022 Jun; 33(4):1816-1837. PubMed ID: 33849384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
    Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
    J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Split-face comparative study between intradermal tranexamic acid injection alone versus intradermal tranexamic acid injection combined with Q-switched Nd:YAG laser in melasma treatment: dermoscopic and clinical evaluation.
    Hawwam SA; Ismail M; El-Attar YA
    Lasers Med Sci; 2022 Jun; 37(4):2193-2201. PubMed ID: 34988730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical therapies for melasma.
    Mahajan VK; Patil A; Blicharz L; Kassir M; Konnikov N; Gold MH; Goldman MP; Galadari H; Goldust M
    J Cosmet Dermatol; 2022 Sep; 21(9):3707-3728. PubMed ID: 35854432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q-switched fractional 1064-nm Nd:YAG laser: A blinded RCT and follow-up.
    Behrangi E; Shemshadi M; Ghassemi M; Goodarzi A; Dilmaghani S
    J Cosmet Dermatol; 2022 Jan; 21(1):279-289. PubMed ID: 34724323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition of refractory melasma and its treatment: a review.
    Yao H; Shen S; Gao X; Feng J; Song X; Xiang W
    Lasers Med Sci; 2024 Apr; 39(1):118. PubMed ID: 38679674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melasma: systematic review of the systemic treatments.
    Zhou LL; Baibergenova A
    Int J Dermatol; 2017 Sep; 56(9):902-908. PubMed ID: 28239840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
    Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
    J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of combined fractional CO
    Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M
    Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the tolerance and efficacy of laser-assisted delivery of tranexamic acid, niacinamide, and kojic acid for melasma: A single center, prospective, split-face trial.
    Park SJ; Park JW; Seo SJ; Park KY
    Dermatol Ther; 2022 Mar; 35(3):e15287. PubMed ID: 34962047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.